国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2011年
4期
385-387
,共3页
高代平%林文武%林军%莫友发%张礼鹃%陈伟琼
高代平%林文武%林軍%莫友髮%張禮鵑%陳偉瓊
고대평%림문무%림군%막우발%장례견%진위경
慢性阻塞性肺部疾病%主肺动脉%右心室肥大%CT测量
慢性阻塞性肺部疾病%主肺動脈%右心室肥大%CT測量
만성조새성폐부질병%주폐동맥%우심실비대%CT측량
Chronic obstructive pulmonary disease(COPD)%Main pulmonary artery%Right ventricular hypertrophy%CT measurements
目的 研究主肺动脉与右心室肥大的相关性.方法 随机选择具有慢性阻塞性肺部疾病患者60例进行CT扫描,根据心电图、超声心动图结果分为右心室肥大组(研究组)和右心室不肥大组(对照组)各30例,在CT上测量主肺动脉直径(MPAD)和升主动脉直径(AAD),计算其比值(MPAD/AAD).结果 于MPAD/AAD≤1.1时,两组之间差异无显著性(P>0.05);于MPAD/AAD>1.1时,两组之间差异有极显著性(P<0.01);以MPAD/AAD>1.1预测右心室肥大的敏感性、特异性、阳性预测值分别为86.7%、96.7%、96.3%.结论 MPAD/AAD>1.1可以作为CT诊断右心室肥大的一种新指标.
目的 研究主肺動脈與右心室肥大的相關性.方法 隨機選擇具有慢性阻塞性肺部疾病患者60例進行CT掃描,根據心電圖、超聲心動圖結果分為右心室肥大組(研究組)和右心室不肥大組(對照組)各30例,在CT上測量主肺動脈直徑(MPAD)和升主動脈直徑(AAD),計算其比值(MPAD/AAD).結果 于MPAD/AAD≤1.1時,兩組之間差異無顯著性(P>0.05);于MPAD/AAD>1.1時,兩組之間差異有極顯著性(P<0.01);以MPAD/AAD>1.1預測右心室肥大的敏感性、特異性、暘性預測值分彆為86.7%、96.7%、96.3%.結論 MPAD/AAD>1.1可以作為CT診斷右心室肥大的一種新指標.
목적 연구주폐동맥여우심실비대적상관성.방법 수궤선택구유만성조새성폐부질병환자60례진행CT소묘,근거심전도、초성심동도결과분위우심실비대조(연구조)화우심실불비대조(대조조)각30례,재CT상측량주폐동맥직경(MPAD)화승주동맥직경(AAD),계산기비치(MPAD/AAD).결과 우MPAD/AAD≤1.1시,량조지간차이무현저성(P>0.05);우MPAD/AAD>1.1시,량조지간차이유겁현저성(P<0.01);이MPAD/AAD>1.1예측우심실비대적민감성、특이성、양성예측치분별위86.7%、96.7%、96.3%.결론 MPAD/AAD>1.1가이작위CT진단우심실비대적일충신지표.
Objective To investigate the correlation between main pulmonary artery and right ventricular hypertrophy. Methods 60 patients with chronic obstructive pulmonary disease were randomly selected and examined with CT scan, under the electrocardiogram, ultrasound and divided into the right ventricular hypertrophy group (observation group) and no right ventricular hypertrophy group (control),30 patients for each. Main pulmonary artery diameter (MPAD) and ascending aorta diameter (AAD) were measured on the CT to calculate the ratio (MPAD/AAD). Results When the MPAD/AAD≤ 1.1, there was no significant difference between the two groups; while MPAD/AAD > 1.1, the two groups were significantly different(P<0.01); when the MPAD/AAD>1.1, it predicts the sensitivity, specificity and positive predictive value of right ventricular hypertrophy were 86.7%, 96.7%, 96.3% respectively. Conclusion MPAD/AAD>1.1 could be a new target for CT diagnosis to right ventricular hypertrophy.